SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-17-007954
Filing Date
2017-05-01
Accepted
2017-05-01 16:53:14
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A (FYE 12.31.16) orex-10ka_20161231.htm 10-K/A 819695
2 EX-31.1 orex-ex311_8.htm EX-31.1 12559
3 EX-31.2 orex-ex312_7.htm EX-31.2 12937
4 EX-32.1 orex-ex321_6.htm EX-32.1 13892
  Complete submission text file 0001564590-17-007954.txt   860121
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33415 | Film No.: 17801545
SIC: 2834 Pharmaceutical Preparations